About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in San Antonio | 221 Studies

Clinical Trials Breast CancerSan Antonio

Breast Cancer Clinical Trials in San Antonio

Find 221 clinical trials for breast cancer near San Antonio, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 221 trials

UnknownFulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerThis is a multi-center, randomized, open-label, parallel group study designed to evaluate efficacy and safety of fulvestrant followed, at progression, by examestane and everolimus…NCT02404051·Asti and 40 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma.NCT02614794·Birmingham, Alabama and 175 others

RecruitingSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaStudy QXL138AM-001 is a Phase 1a/1b study to investigate the safety, pharmacokinetics, and preliminary activity of QXL138AM in subjects with locally advanced un-resectable and/or…NCT06582017·Los Angeles, California and 9 others

Active not recruitingStudy of LP-184 in Patients With Advanced Solid TumorsThe primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory…NCT05933265·Springdale, Arkansas and 6 others

RecruitingAdding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerThis phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2…NCT06058377·Birmingham, Alabama and 557 others

Active not recruitingEndocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerThe purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor…NCT03155997·Birmingham, Alabama and 618 others

CompletedXpress Digital Mammography System Images for Computer Aided Detection DevelopmentThe primary objective of this study is to acquire digital mammography images produced by the Xpress Digital Mammography System in order to develop Computer Aided Detection…NCT01061138·Waterbury, Connecticut and 4 others

WithdrawnA Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast CancerThe reason for this study is to see if the drug abemaciclib in combination with nonsteroidal aromatase inhibitors (anastrozole or letrozole) is effective in participants with…NCT03988114·Daphne, Alabama and 118 others

CompletedVaccine Therapy in Treating Patients With Breast CancerRATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells that express HER2/neu.NCT00524277·Washington D.C., District of Columbia and 12 others

CompletedSafety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast CancerThis trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer.NCT03310957·Birmingham, Alabama and 49 others

RecruitingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsThe goal of this open-label dose escalation and expansion study is to evaluate the safety and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast…NCT07029399·Duarte, California and 17 others

CompletedA Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentThis two-cohort, open-label, multicenter study will assess the safety, efficacy and tolerability of trastuzumab emtansine in participants with HER2-positive locally advanced…NCT01702571·Buenos Aires and 299 others

CompletedA Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K ActivationThis study evaluated whether the addition of daily BKM120 to weekly paclitaxel was effective and safe in treating patients with HER2- locally advanced or metastatic breast cancer.NCT01572727·Chandler, Arizona and 111 others

Active not recruitingHigher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryRATIONALE: It is not yet know whether higher per daily radiation therapy is equally as effective as standard per daily radiation therapy in treating breast cancer.NCT01349322·Birmingham, Alabama and 414 others

CompletedA Multi-Reader Multi-Case Pivotal TrialThe purpose of this pivotal reader study is to assess the comparative accuracy of Fujifilm FFDM plus DBT versus FFDM alone in the detection of breast cancer.NCT02692209·Scottsdale, Arizona and 4 others

Active not recruitingTesting Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain MetastasesThis phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases).NCT04647916·Anchorage, Alaska and 295 others

RecruitingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib and palbociclib plus endocrine therapy for the treatment of patients…NCT06757634·Duarte, California and 202 others

CompletedChemotherapy in Treating Women With Breast Cancer That Can Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002707·Huntsville, Alabama and 144 others

RecruitingA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back…NCT06966700·Gilbert, Arizona and 324 others

RecruitingBreast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:This is a multicenter observational study with both retrospective and prospective phase, designed to evaluate the clinico-pathologic characteristics and outcomes of patients with…NCT07180693·Bergamo, Italy and 17 others

Page 1 of 12Next

Other Conditions in San Antonio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma